Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
Objective: To determine whether pretreatment with amifostine would reduce the toxicity of cisplatin with no reduction in antitumor efficacy in patients with advanced non-small lung cancer. Patients and Method: Patients with locally advanced or metastatic non-small cell lung cancer, aged less than 75...
Saved in:
Main Authors: | Thongprasert S., Chewaskulyong B. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-8444227474&partnerID=40&md5=9088be1e70aa109c07260135eac0045a http://www.ncbi.nlm.nih.gov/pubmed/15560691 http://cmuir.cmu.ac.th/handle/6653943832/3830 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014) -
Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer
by: Chewaskulyong B., et al.
Published: (2014) -
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014) -
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014) -
Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer
by: Sumitra Thongprasert, et al.
Published: (2018)